Consultation outcome

Proposal to make Sildenafil 50mg film-coated tablets available from Pharmacies

• From: Medicines and Healthcare products Regulatory Agency
• Published: 28 March 2017
• Last updated: 28 November 2017 — See all updates

This consultation has concluded

Read the full outcome

Viagra Connect reclassification public assessment report

PDF, 88.8 KB, 14 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail of outcome

The Medicines and Healthcare products Regulatory Agency (MHRA) has agreed to reclassify Viagra Connect from a prescription only medicine (POM) to a Pharmacy (P) medicine in the UK for the treatment of erectile dysfunction in men aged 18 years and over.

See the public assessment report for more information.

Feedback received

Summary table of responses on proposed POM to P reclassification for sildenafil tablets

PDF, 103 KB, 18 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Detail of feedback received

Consultation document ARM94, which summarises the proposals on the pharmacy only (POM) to pharmacy (P) reclassification of Viagra Connect, was posted on the GOV.UK website on 27 March 2017. The deadline for comments was given as 18 April 2017.

47 responses to the consultation were received. 33 responses supported the proposal, 13 did not support the proposal, and 1 was unsure about the proposal. 24 were confidential.

---

Original consultation

Summary

We are considering making Sildenafil 50mg film-coated tablets available to buy from pharmacies. We always want to involve the public and healthcare professionals in decisions that affect them. We want to know what you think about this change.

This consultation ran from
9:30am on 27 March 2017 to 5pm on 18 April 2017

Consultation description

We want to know what you think

• Sildenafil 50mg tablets are used to treat erectile dysfunction in adult men aged 18 years or over.
• Sildenafil 50mg tablets are only at the moment available on prescription.
• We propose to make it available in pharmacies.
• We consider that this product can be available as a Pharmacy medicine.
• We want to know what you think about this change.

Please tell us your views using the form at the end of the attached pdf.

The deadline for comments is 18 April 2017.

Documents

Sildenafil public reclassification report for consultation.

PDF, 5.46 MB, 33 pages

Sildenafil response form

MS Word Document, 229 KB

Published 28 March 2017
Last updated 28 November 2017 + show all updates

1. 28 November 2017

   Added final outcome of the consultation.

2. 28 March 2017

   First published.